Having trouble accessing articles? Reset your cache.

ViaDerm-GLP1 agonist: Phase Ia data

Data from a 3-way crossover Phase Ia trial in 12 patients showed that

Read the full 134 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE